引導式測驗 · 中等 等級
FDA 對人工智慧醫療設備的監管測驗
測試 510(k)、De Novo 和 PMA 路徑、AI 更新的預定變更控制計劃,以及 EU MDR 和 AI Act 規則如何應用於 AI 裝置。
問題 1 的 8
What must a manufacturer show to obtain 510(k) clearance?
預覽每個問題8 問題
當您參加測驗時,就會出現答案和解釋。
- What must a manufacturer show to obtain 510(k) clearance?
- That the device is substantially equivalent to a legally marketed predicate device
- That the device has completed three phases of randomized clinical trials
- That the device has no predicate and is low to moderate risk
- That the device learns continuously from patient data
- The FDA authorized IDx-DR, an autonomous AI for diabetic retinopathy, in 2018. Which pathway did it use, and why?
- PMA, because every diagnostic AI is Class III
- 510(k), because many retinal cameras already existed
- De Novo, because it was novel and had no suitable predicate
- It needed no authorization under the Cures Act exclusion
- What does a predetermined change control plan (PCCP) allow?
- Selling a device before the FDA has reviewed it
- Making specified, pre-validated modifications to an AI device without a new submission for each one
- Letting a model rewrite its own intended use in the field
- Skipping postmarket monitoring
- Which three parts make up a PCCP?
- Predicate list, clinical trial, and labeling
- Risk class, user fee, and establishment registration
- Algorithm source code, training data, and patent filings
- Description of modifications, modification protocol, and impact assessment
- Which statement about most FDA-authorized AI devices is accurate?
- They are generally locked models that change only through controlled updates
- They retrain themselves automatically on every patient they see
- They are all Class III devices approved through PMA
- They are mostly used in dermatology
- Under the 21st Century Cures Act, which kind of software can fall outside the definition of a device?
- Software that analyzes medical images to detect tumors
- Any software sold by a hospital
- Clinical decision support that shows clinicians the basis for its recommendations so they can review them independently
- Any software that uses machine learning
- Under the EU Medical Device Regulation, which rule classifies software, and where does most diagnostic software end up?
- Rule 1, which puts it in Class I
- Rule 11, which puts most of it in Class IIa or higher
- Annex XVI, which exempts it
- Rule 22, which places all software in Class III
- Why do reviewers ask for AI device performance broken down by subgroup and acquisition equipment?
- To calculate user fees
- To choose a predicate device
- To decide whether the device is Class I
- Because models can fail when patient populations or equipment such as scanner vendors differ from the training data